Product Information

DEXTROAMP-AMPHET ER 30 MG CAP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.4857 per EA under NDC 57664034188. Its NADAC has been published 285 times since Sep 9, 2020.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

NDC

57664034188

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

2/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211715

On Market Since

3/5/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has been published 285 times since Sep 9, 2020, and over the history we have for it it has declined 69.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4857 per EA
All-time high$1.5747 (Sep 16, 2020)
All-time low$0.3360 (May 22, 2024)
52-week high$0.5944
52-week low$0.4621
Median price$0.6354
Average price$0.6408
Largest weekly change+61.4% (Jun 19, 2024)
Weeks tracked285
Tracking sinceSep 9, 2020

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.1%

1Y

-18.3%

3Y

-32.7%

5Y

-33.4%

All

-69.2%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHET ER 30 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 30 MG CAP, manufactured by Sun Pharmaceutical Industries Inc., is $0.4857 per EA (NDC 57664034188), effective Feb 18, 2026.

How has the price of DEXTROAMP-AMPHET ER 30 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has declined 69.2%. It has been tracked across 285 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 30 MG CAP?

Since Sep 9, 2020, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has ranged from a low of $0.3360 (May 22, 2024) to a high of $1.5747 (Sep 16, 2020), with a median of $0.6354 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHET ER 30 MG CAP?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as DEXTROAMP-AMPHET ER 30 MG CAP, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHET ER 30 MG CAP?

DEXTROAMP-AMPHET ER 30 MG CAP (NDC 57664034188) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.